Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

The Johann Jacob Wepfer Award

Free Access

Evolution from Stroke Risk Factors to Brain Health Determinants

11th Johann Jacob Wepfer Lecture, European Stroke Conference, Vienna, Austria 2015

Sacco R.L.

Author affiliations

Olemberg Family Chair in Neurological Disorders, Miller Professor of Neurology, Public Health Sciences, Human Genetics, and Neurosurgery, Executive Director, Evelyn McKnight Brain Institute, Miller School of Medicine, University of Miami, Chief of Service, Jackson Memorial Hospital, Miami, Fla., USA

Corresponding Author

Ralph L. Sacco, MS, MD, FAAN, FAHA

Miller School of Medicine, University of Miami

Clinical Research Building, 1120 NW 14th Street, Suite 1352

Miami, FL 33136 (USA)

E-Mail RSacco@med.miami.edu

Related Articles for ""

Cerebrovasc Dis 2015;40:102-113

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.




First-Page Preview
Abstract of The Johann Jacob Wepfer Award

References

  1. Sacco RL, Wolf PA, Kannel WB, McNamara PM: Survival and recurrence following stroke. The Framingham Study. Stroke 1982;13:290-295.
  2. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T, O'Donnell M, Venketasubramanian N, Barker-Collo S, Lawes CM, Wang W, Shinohara Y, Witt E, Ezzati M, Naghavi M, Murray C; Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) and the GBD Stroke Experts Group: Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 2014;383:245-254.
  3. Blazer DG, Yaffe K, Liverman CT (eds): Cognitive Aging: Progress in Understanding and Opportunities for Action. Washington, National Academies Press, 2015. http://www.iom.edu/cognitiveaging (accessed April 14, 2015).
  4. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd: Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study. Ann Intern Med 1961;55:33-50.
  5. Sacco RL, Boden-Albala B, Gan R, Kargman DE, Paik M, Shea S, Hauser WA: Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259-268.
  6. Gardener H, Sjoberg C, Crisby M, Goldberg R, Mendez A, Wright CB, Elkind MS, Sacco RL, Rundek T: Adiponectin and carotid intima-media thickness in the Northern Manhattan Study. Stroke 2011;43:1123-1125.
  7. Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL: Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology 2008;70:1200-1207.
  8. Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MS, Sacco RL, Rundek T: Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 2012;43:1755-1760.
  9. Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, Rundek T: Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke 2013;44:457-461.
  10. Rundek T, Blanton SH, Bartels S, Dong C, Raval A, Demmer RT, Cabral D, Elkind MS, Sacco RL, Desvarieux M: Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke 2013;44:2101-2108.
  11. Di Tullio MR, Sacco RL, Sciacca RR, Homma S: Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 1999;30:2019-2024.
  12. Kohsaka S, Sciacca RR, Sugioka K, Sacco RL, Homma S, Di Tullio MR: Electrocardiographic left atrial abnormalities and risk of ischemic stroke. Stroke 2005;36:2481-2483.
  13. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S: Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 2003;34:2380-2384.
  14. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S: Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol 2007;49:797-802.
  15. Di Tullio MR, Jin Z, Russo C, Elkind MS, Rundek T, Yoshita M, Decarli C, Wright CB, Homma S, Sacco RL: Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. J Am Coll Cardiol 2013;62:35-41.
  16. Russo C, Jin Z, Liu R, Homma S, Elkind MS, Rundek T, DeCarli C, Wright CB, Sacco RL, Di Tullio MR: LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the cardiac abnormalities and brain lesions (CABL) study. JACC Cardiovasc Imaging 2013;6:313-323.
  17. Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281:53-60.
  18. Elkind MS, Sciacca R, Boden-Albala B, Rundek T, Paik MC, Sacco RL: Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006;37:13-19.
  19. Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL: Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care 2008;31:1132-1137.
  20. Boden-Albala B, Kargman DE, Lin IF, Paik MC, Sacco RL, Berglund L: Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study. Cerebrovasc Dis 2010;30:237-243.
  21. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, Sacco RL, Elkind MS: Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study. Stroke 2012;43:1212-1217.
  22. Willey JZ, Moon YP, Kahn E, Rodriguez CJ, Rundek T, Cheung K, Sacco RL, Elkind MS: Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the Northern Manhattan Study. J Am Heart Assoc 2014;3:e001106.
  23. Sacco RL, Gan R, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke 1998;29:380-387.
  24. Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MS: Physical activity and risk of ischemic stroke in the Northern Manhattan Study (NOMAS). Neurology 2009;73:1774-1779.
  25. Boden-Albala B, Roberts ET, Bazil C, Moon Y, Elkind MS, Rundek T, Paik MC, Sacco RL: Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes 2012;5:500-507.
  26. Monteith T, Gardener H, Rundek T, Dong C, Yoshita M, Elkind MS, DeCarli C, Sacco RL, Wright C: Migraine, white matter hyperintensities, and subclinical brain infarction in a diverse community: the Northern Manhattan Study. Stroke 2014;45:1830-1832.
  27. Gardener H, Wright CB, Gu Y, Demmer RT, Boden-Albala B, Elkind MS, Sacco RL, Scarmeas N: Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr 2011;94:1458-1464.
  28. Gardener H, Rundek T, Markert M, Wright CB, Elkind MS, Sacco RL: Diet soft drink consumption is associated with an increased risk of vascular events in the Northern Manhattan Study. J Gen Intern Med 2012;27:1120-1126.
  29. Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL: Dietary sodium and risk of stroke in the Northern Manhattan Study. Stroke 2012;43:1200-1205.
  30. Rundek T, Gardener H, Xu Q, Goldberg RB, Wright CB, Boden-Albala B, Disla N, Paik MC, Elkind MS, Sacco RL: Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the Northern Manhattan Study. Arch Neurol 2010;67:1195-1200.
  31. Kannel WB, McGee D, Gordon T: A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976;38:46-51.
  32. Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC: Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study). J Am Coll Cardiol 2009;54:2303-2311.
  33. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force and Statistics Committee: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond. Circulation 2010;121:586-613.
  34. Dong C, Rundek T, Wright CB, Anwar Z, Elkind MS, Sacco RL: Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across Whites, Black, and Hispanics: the Northern Manhattan Study. Circulation 2012;125:2975-2984.
  35. Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD; ARIC Study Investigators: Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol 2011;57:1690-1696.
  36. Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS: Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation 2014;130:1676-1683.
  37. Zhang Q, Zhou Y, Gao X, Wang C, Zhang S, Wang A, Li N, Bian L, Wu J, Jia Q, Wu S, Zhao X: Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-2456.
  38. Ford ES, Greenlund KJ, Hong Y: Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the United States. Circulation 2012;125:987-995.
  39. Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS: Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study. Ann Epidemiol 2014;24:362-368.
  40. Dhamoon MS, Dong C, Elkind MS, Sacco RL: Ideal cardiovascular health predicts functional status independently of vascular events: the Northern Manhattan Study. J Am Heart Assoc 2015;4:e001322.
  41. Boden-Albala B, Sacco RL, Lee HS, Grahame-Clarke C, Rundek T, Elkind MV, Wright C, Giardina EG, DiTullio MR, Homma S, Paik MC: Metabolic syndrome and ischemic stroke risk: the Northern Manhattan Study. Stroke 2008;39:30-35.
  42. Vieira JR, Elkind MS, Moon YP, Rundek T, Boden-Albala B, Paik MC, Sacco RL, Wright CB: The metabolic syndrome and cognitive performance: the Northern Manhattan Study. Neuroepidemiology 2011;37:153-159.
  43. Levin BE, Llabre MM, Dong C, Elkind MS, Stern Y, Rundek T, Sacco RL, Wright CB: Modeling metabolic syndrome and its association with cognition: the Northern Manhattan Study. J Int Neuropsychol Soc 2014;20:951-960.
  44. Russo C, Jin Z, Elkind MS, Rundek T, Homma S, Sacco RL, Di Tullio MR: Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail 2014;16:1301-1309.
  45. Russo C, Jin Z, Homma S, Elkind MS, Rundek T, Yoshita M, DeCarli C, Wright CB, Sacco RL, Di Tullio MR: Subclinical left ventricular dysfunction and silent cerebrovascular disease: the cardiovascular abnormalities and brain lesions (CABL) study. Circulation 2013;128:1105-1111.
  46. Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ: Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol 2015;11:323-331.
  47. Magnani JW, Zhu L, Lopez F, Pencina MJ, Agarwal SK, Soliman EZ, Benjamin EJ, Alonso A: P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and atherosclerosis risk in communities (ARIC) study. Am Heart J 2015;169:53-61.e1.
  48. Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, Yoshita M, DeCarli C, Sacco R, Elkind MS: Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009;40:3466-3471.
  49. Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL: Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study. Neurology 2008;70:425-430.
  50. Marcus J, Gardener H, Rundek T, Elkind MS, Sacco RL, Decarli C, Wright CB: Baseline and longitudinal increases in diastolic blood pressure are associated with greater white matter hyperintensity volume: the Northern Manhattan Study. Stroke 2011;42:2639-2641.
  51. Wright CB, Festa JR, Paik MC, Schmiedigen A, Brown TR, Yoshita M, DeCarli C, Sacco R, Stern Y: White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke 2008;39:800-805.
  52. Fanning JP, Wong AA, Fraser JF: The epidemiology of silent brain infarction: systematic review of population-based cohorts. BMC Med 2014;12:119.
  53. Gutierrez J, Bagci A, Gardener H, Rundek T, Ekind MS, Alperin N, Sacco RL, Wright CB: Dolichoectasia diagnostic methods in a multi-ethnic, stroke-free cohort: results from the Northern Manhattan Study. J Neuroimaging 2014;24:226-231.
  54. Gutierrez J, Rundek T, Ekind MS, Sacco RL, Wright CB: Perivascular spaces are associated with atherosclerosis: an insight from the Northern Manhattan Study. AJNR Am J Neuroradiol 2013;34:1711-1716.
  55. Elkind MS: Infectious burden: a new risk factor and treatment target for atherosclerosis. Infect Disord Drug Targets 2010;10:84-90.
  56. Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC: Infectious burden and risk of stroke: the Northern Manhattan Study. Arch Neurol 2010;67:33-38.
  57. Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC: Infectious burden and carotid plaque thickness: the Northern Manhattan Study. Stroke 2010;41:e117-e122.
  58. Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS: Infectious burden and cognitive function: the NOMAS. Neurology 2013;80:1209-1215.

Article / Publication Details

Published online: July 18, 2015
Issue release date: September 2015

Number of Print Pages: 12
Number of Figures: 5
Number of Tables: 1

ISSN: 1015-9770 (Print)
eISSN: 1421-9786 (Online)

For additional information: https://www.karger.com/CED


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.